Global Pandemic Influenza Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Page: 90

Published Date: 05 Jan 2022

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Pandemic Influenza Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Pandemic Influenza Vaccine market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during review period. For Children (6 months to 3 years) accounting for % of the Pandemic Influenza Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Whole Virus Vaccines segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Pandemic Influenza Vaccine include CSL, GSK, Sanofi Pasteur, Mylan, and AstraZeneca, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation
Pandemic Influenza Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Whole Virus Vaccines
    Split Virus Vaccines
    Subunit Vaccines

Market segment by Application can be divided into
    For Children (6 months to 3 years)
    For Adults and Children over 3 years

The key market players for global Pandemic Influenza Vaccine market are listed below:
    CSL
    GSK
    Sanofi Pasteur
    Mylan
    AstraZeneca
    Pfizer
    Johnson & Johnson

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pandemic Influenza Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pandemic Influenza Vaccine, with price, sales, revenue and global market share of Pandemic Influenza Vaccine from 2019 to 2022.
Chapter 3, the Pandemic Influenza Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pandemic Influenza Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Pandemic Influenza Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pandemic Influenza Vaccine.
Chapter 13, 14, and 15, to describe Pandemic Influenza Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Pandemic Influenza Vaccine Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Pandemic Influenza Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Whole Virus Vaccines
        1.2.3 Split Virus Vaccines
        1.2.4 Subunit Vaccines
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Pandemic Influenza Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 For Children (6 months to 3 years)
        1.3.3 For Adults and Children over 3 years
    1.4 Global Pandemic Influenza Vaccine Market Size & Forecast
        1.4.1 Global Pandemic Influenza Vaccine Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global Pandemic Influenza Vaccine Sales in Volume (2017-2028)
        1.4.3 Global Pandemic Influenza Vaccine Price (2017-2028)
    1.5 Global Pandemic Influenza Vaccine Production Capacity Analysis
        1.5.1 Global Pandemic Influenza Vaccine Total Production Capacity (2017-2028)
        1.5.2 Global Pandemic Influenza Vaccine Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Pandemic Influenza Vaccine Market Drivers
        1.6.2 Pandemic Influenza Vaccine Market Restraints
        1.6.3 Pandemic Influenza Vaccine Trends Analysis

2 Manufacturers Profiles
    2.1 CSL
        2.1.1 CSL Details
        2.1.2 CSL Major Business
        2.1.3 CSL Pandemic Influenza Vaccine Product and Services
        2.1.4 CSL Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 GSK
        2.2.1 GSK Details
        2.2.2 GSK Major Business
        2.2.3 GSK Pandemic Influenza Vaccine Product and Services
        2.2.4 GSK Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 Sanofi Pasteur
        2.3.1 Sanofi Pasteur Details
        2.3.2 Sanofi Pasteur Major Business
        2.3.3 Sanofi Pasteur Pandemic Influenza Vaccine Product and Services
        2.3.4 Sanofi Pasteur Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 Mylan
        2.4.1 Mylan Details
        2.4.2 Mylan Major Business
        2.4.3 Mylan Pandemic Influenza Vaccine Product and Services
        2.4.4 Mylan Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 AstraZeneca
        2.5.1 AstraZeneca Details
        2.5.2 AstraZeneca Major Business
        2.5.3 AstraZeneca Pandemic Influenza Vaccine Product and Services
        2.5.4 AstraZeneca Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 Pfizer
        2.6.1 Pfizer Details
        2.6.2 Pfizer Major Business
        2.6.3 Pfizer Pandemic Influenza Vaccine Product and Services
        2.6.4 Pfizer Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.7 Johnson & Johnson
        2.7.1 Johnson & Johnson Details
        2.7.2 Johnson & Johnson Major Business
        2.7.3 Johnson & Johnson Pandemic Influenza Vaccine Product and Services
        2.7.4 Johnson & Johnson Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Pandemic Influenza Vaccine Breakdown Data by Manufacturer
    3.1 Global Pandemic Influenza Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global Pandemic Influenza Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in Pandemic Influenza Vaccine
    3.4 Market Concentration Rate
        3.4.1 Top 3 Pandemic Influenza Vaccine Manufacturer Market Share in 2021
        3.4.2 Top 6 Pandemic Influenza Vaccine Manufacturer Market Share in 2021
    3.5 Global Pandemic Influenza Vaccine Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and Pandemic Influenza Vaccine Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Pandemic Influenza Vaccine Market Size by Region
        4.1.1 Global Pandemic Influenza Vaccine Sales in Volume by Region (2017-2028)
        4.1.2 Global Pandemic Influenza Vaccine Revenue by Region (2017-2028)
    4.2 North America Pandemic Influenza Vaccine Revenue (2017-2028)
    4.3 Europe Pandemic Influenza Vaccine Revenue (2017-2028)
    4.4 Asia-Pacific Pandemic Influenza Vaccine Revenue (2017-2028)
    4.5 South America Pandemic Influenza Vaccine Revenue (2017-2028)
    4.6 Middle East and Africa Pandemic Influenza Vaccine Revenue (2017-2028)

5 Market Segment by Type
    5.1 Global Pandemic Influenza Vaccine Sales in Volume by Type (2017-2028)
    5.2 Global Pandemic Influenza Vaccine Revenue by Type (2017-2028)
    5.3 Global Pandemic Influenza Vaccine Price by Type (2017-2028)

6 Market Segment by Application
    6.1 Global Pandemic Influenza Vaccine Sales in Volume by Application (2017-2028)
    6.2 Global Pandemic Influenza Vaccine Revenue by Application (2017-2028)
    6.3 Global Pandemic Influenza Vaccine Price by Application (2017-2028)

7 North America by Country, by Type, and by Application
    7.1 North America Pandemic Influenza Vaccine Sales by Type (2017-2028)
    7.2 North America Pandemic Influenza Vaccine Sales by Application (2017-2028)
    7.3 North America Pandemic Influenza Vaccine Market Size by Country
        7.3.1 North America Pandemic Influenza Vaccine Sales in Volume by Country (2017-2028)
        7.3.2 North America Pandemic Influenza Vaccine Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application
    8.1 Europe Pandemic Influenza Vaccine Sales by Type (2017-2028)
    8.2 Europe Pandemic Influenza Vaccine Sales by Application (2017-2028)
    8.3 Europe Pandemic Influenza Vaccine Market Size by Country
        8.3.1 Europe Pandemic Influenza Vaccine Sales in Volume by Country (2017-2028)
        8.3.2 Europe Pandemic Influenza Vaccine Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application
    9.1 Asia-Pacific Pandemic Influenza Vaccine Sales by Type (2017-2028)
    9.2 Asia-Pacific Pandemic Influenza Vaccine Sales by Application (2017-2028)
    9.3 Asia-Pacific Pandemic Influenza Vaccine Market Size by Region
        9.3.1 Asia-Pacific Pandemic Influenza Vaccine Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific Pandemic Influenza Vaccine Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application
    10.1 South America Pandemic Influenza Vaccine Sales by Type (2017-2028)
    10.2 South America Pandemic Influenza Vaccine Sales by Application (2017-2028)
    10.3 South America Pandemic Influenza Vaccine Market Size by Country
        10.3.1 South America Pandemic Influenza Vaccine Sales in Volume by Country (2017-2028)
        10.3.2 South America Pandemic Influenza Vaccine Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Pandemic Influenza Vaccine Sales by Type (2017-2028)
    11.2 Middle East & Africa Pandemic Influenza Vaccine Sales by Application (2017-2028)
    11.3 Middle East & Africa Pandemic Influenza Vaccine Market Size by Country
        11.3.1 Middle East & Africa Pandemic Influenza Vaccine Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa Pandemic Influenza Vaccine Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain
    12.1 Raw Material of Pandemic Influenza Vaccine and Key Manufacturers
    12.2 Manufacturing Costs Percentage of Pandemic Influenza Vaccine
    12.3 Pandemic Influenza Vaccine Production Process
    12.4 Pandemic Influenza Vaccine Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 Pandemic Influenza Vaccine Typical Distributors
    13.3 Pandemic Influenza Vaccine Typical Customers

14 Research Findings and Conclusion

15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Pandemic Influenza Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
    Table 2. Global Pandemic Influenza Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
    Table 3. CSL Basic Information, Manufacturing Base and Competitors
    Table 4. CSL Major Business
    Table 5. CSL Pandemic Influenza Vaccine Product and Services
    Table 6. CSL Pandemic Influenza Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 7. GSK Basic Information, Manufacturing Base and Competitors
    Table 8. GSK Major Business
    Table 9. GSK Pandemic Influenza Vaccine Product and Services
    Table 10. GSK Pandemic Influenza Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 11. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
    Table 12. Sanofi Pasteur Major Business
    Table 13. Sanofi Pasteur Pandemic Influenza Vaccine Product and Services
    Table 14. Sanofi Pasteur Pandemic Influenza Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 15. Mylan Basic Information, Manufacturing Base and Competitors
    Table 16. Mylan Major Business
    Table 17. Mylan Pandemic Influenza Vaccine Product and Services
    Table 18. Mylan Pandemic Influenza Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 19. AstraZeneca Basic Information, Manufacturing Base and Competitors
    Table 20. AstraZeneca Major Business
    Table 21. AstraZeneca Pandemic Influenza Vaccine Product and Services
    Table 22. AstraZeneca Pandemic Influenza Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 23. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 24. Pfizer Major Business
    Table 25. Pfizer Pandemic Influenza Vaccine Product and Services
    Table 26. Pfizer Pandemic Influenza Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 27. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
    Table 28. Johnson & Johnson Major Business
    Table 29. Johnson & Johnson Pandemic Influenza Vaccine Product and Services
    Table 30. Johnson & Johnson Pandemic Influenza Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 31. Global Pandemic Influenza Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Doses)
    Table 32. Global Pandemic Influenza Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
    Table 33. Market Position of Manufacturers in Pandemic Influenza Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
    Table 34. Global Pandemic Influenza Vaccine Production Capacity by Company, (K Doses): 2020 VS 2021
    Table 35. Head Office and Pandemic Influenza Vaccine Production Site of Key Manufacturer
    Table 36. Pandemic Influenza Vaccine New Entrant and Capacity Expansion Plans
    Table 37. Pandemic Influenza Vaccine Mergers & Acquisitions in the Past Five Years
    Table 38. Global Pandemic Influenza Vaccine Sales by Region (2017-2022) & (K Doses)
    Table 39. Global Pandemic Influenza Vaccine Sales by Region (2023-2028) & (K Doses)
    Table 40. Global Pandemic Influenza Vaccine Revenue by Region (2017-2022) & (USD Million)
    Table 41. Global Pandemic Influenza Vaccine Revenue by Region (2023-2028) & (USD Million)
    Table 42. Global Pandemic Influenza Vaccine Sales by Type (2017-2022) & (K Doses)
    Table 43. Global Pandemic Influenza Vaccine Sales by Type (2023-2028) & (K Doses)
    Table 44. Global Pandemic Influenza Vaccine Revenue by Type (2017-2022) & (USD Million)
    Table 45. Global Pandemic Influenza Vaccine Revenue by Type (2023-2028) & (USD Million)
    Table 46. Global Pandemic Influenza Vaccine Price by Type (2017-2022) & (USD/Dose)
    Table 47. Global Pandemic Influenza Vaccine Price by Type (2023-2028) & (USD/Dose)
    Table 48. Global Pandemic Influenza Vaccine Sales by Application (2017-2022) & (K Doses)
    Table 49. Global Pandemic Influenza Vaccine Sales by Application (2023-2028) & (K Doses)
    Table 50. Global Pandemic Influenza Vaccine Revenue by Application (2017-2022) & (USD Million)
    Table 51. Global Pandemic Influenza Vaccine Revenue by Application (2023-2028) & (USD Million)
    Table 52. Global Pandemic Influenza Vaccine Price by Application (2017-2022) & (USD/Dose)
    Table 53. Global Pandemic Influenza Vaccine Price by Application (2023-2028) & (USD/Dose)
    Table 54. North America Pandemic Influenza Vaccine Sales by Country (2017-2022) & (K Doses)
    Table 55. North America Pandemic Influenza Vaccine Sales by Country (2023-2028) & (K Doses)
    Table 56. North America Pandemic Influenza Vaccine Revenue by Country (2017-2022) & (USD Million)
    Table 57. North America Pandemic Influenza Vaccine Revenue by Country (2023-2028) & (USD Million)
    Table 58. North America Pandemic Influenza Vaccine Sales by Type (2017-2022) & (K Doses)
    Table 59. North America Pandemic Influenza Vaccine Sales by Type (2023-2028) & (K Doses)
    Table 60. North America Pandemic Influenza Vaccine Sales by Application (2017-2022) & (K Doses)
    Table 61. North America Pandemic Influenza Vaccine Sales by Application (2023-2028) & (K Doses)
    Table 62. Europe Pandemic Influenza Vaccine Sales by Country (2017-2022) & (K Doses)
    Table 63. Europe Pandemic Influenza Vaccine Sales by Country (2023-2028) & (K Doses)
    Table 64. Europe Pandemic Influenza Vaccine Revenue by Country (2017-2022) & (USD Million)
    Table 65. Europe Pandemic Influenza Vaccine Revenue by Country (2023-2028) & (USD Million)
    Table 66. Europe Pandemic Influenza Vaccine Sales by Type (2017-2022) & (K Doses)
    Table 67. Europe Pandemic Influenza Vaccine Sales by Type (2023-2028) & (K Doses)
    Table 68. Europe Pandemic Influenza Vaccine Sales by Application (2017-2022) & (K Doses)
    Table 69. Europe Pandemic Influenza Vaccine Sales by Application (2023-2028) & (K Doses)
    Table 70. Asia-Pacific Pandemic Influenza Vaccine Sales by Region (2017-2022) & (K Doses)
    Table 71. Asia-Pacific Pandemic Influenza Vaccine Sales by Region (2023-2028) & (K Doses)
    Table 72. Asia-Pacific Pandemic Influenza Vaccine Revenue by Region (2017-2022) & (USD Million)
    Table 73. Asia-Pacific Pandemic Influenza Vaccine Revenue by Region (2023-2028) & (USD Million)
    Table 74. Asia-Pacific Pandemic Influenza Vaccine Sales by Type (2017-2022) & (K Doses)
    Table 75. Asia-Pacific Pandemic Influenza Vaccine Sales by Type (2023-2028) & (K Doses)
    Table 76. Asia-Pacific Pandemic Influenza Vaccine Sales by Application (2017-2022) & (K Doses)
    Table 77. Asia-Pacific Pandemic Influenza Vaccine Sales by Application (2023-2028) & (K Doses)
    Table 78. South America Pandemic Influenza Vaccine Sales by Country (2017-2022) & (K Doses)
    Table 79. South America Pandemic Influenza Vaccine Sales by Country (2023-2028) & (K Doses)
    Table 80. South America Pandemic Influenza Vaccine Revenue by Country (2017-2022) & (USD Million)
    Table 81. South America Pandemic Influenza Vaccine Revenue by Country (2023-2028) & (USD Million)
    Table 82. South America Pandemic Influenza Vaccine Sales by Type (2017-2022) & (K Doses)
    Table 83. South America Pandemic Influenza Vaccine Sales by Type (2023-2028) & (K Doses)
    Table 84. South America Pandemic Influenza Vaccine Sales by Application (2017-2022) & (K Doses)
    Table 85. South America Pandemic Influenza Vaccine Sales by Application (2023-2028) & (K Doses)
    Table 86. Middle East & Africa Pandemic Influenza Vaccine Sales by Region (2017-2022) & (K Doses)
    Table 87. Middle East & Africa Pandemic Influenza Vaccine Sales by Region (2023-2028) & (K Doses)
    Table 88. Middle East & Africa Pandemic Influenza Vaccine Revenue by Region (2017-2022) & (USD Million)
    Table 89. Middle East & Africa Pandemic Influenza Vaccine Revenue by Region (2023-2028) & (USD Million)
    Table 90. Middle East & Africa Pandemic Influenza Vaccine Sales by Type (2017-2022) & (K Doses)
    Table 91. Middle East & Africa Pandemic Influenza Vaccine Sales by Type (2023-2028) & (K Doses)
    Table 92. Middle East & Africa Pandemic Influenza Vaccine Sales by Application (2017-2022) & (K Doses)
    Table 93. Middle East & Africa Pandemic Influenza Vaccine Sales by Application (2023-2028) & (K Doses)
    Table 94. Pandemic Influenza Vaccine Raw Material
    Table 95. Key Manufacturers of Pandemic Influenza Vaccine Raw Materials
    Table 96. Direct Channel Pros & Cons
    Table 97. Indirect Channel Pros & Cons
    Table 98. Pandemic Influenza Vaccine Typical Distributors
    Table 99. Pandemic Influenza Vaccine Typical Customers
List of Figures
    Figure 1. Pandemic Influenza Vaccine Picture
    Figure 2. Global Pandemic Influenza Vaccine Revenue Market Share by Type in 2021
    Figure 3. Whole Virus Vaccines
    Figure 4. Split Virus Vaccines
    Figure 5. Subunit Vaccines
    Figure 6. Global Pandemic Influenza Vaccine Revenue Market Share by Application in 2021
    Figure 7. For Children (6 months to 3 years)
    Figure 8. For Adults and Children over 3 years
    Figure 9. Global Pandemic Influenza Vaccine Revenue, (USD Million) & (K Doses): 2017 & 2021 & 2028
    Figure 10. Global Pandemic Influenza Vaccine Revenue and Forecast (2017-2028) & (USD Million)
    Figure 11. Global Pandemic Influenza Vaccine Sales (2017-2028) & (K Doses)
    Figure 12. Global Pandemic Influenza Vaccine Price (2017-2028) & (USD/Dose)
    Figure 13. Global Pandemic Influenza Vaccine Production Capacity (2017-2028) & (K Doses)
    Figure 14. Global Pandemic Influenza Vaccine Production Capacity by Geographic Region: 2022 VS 2028
    Figure 15. Pandemic Influenza Vaccine Market Drivers
    Figure 16. Pandemic Influenza Vaccine Market Restraints
    Figure 17. Pandemic Influenza Vaccine Market Trends
    Figure 18. Global Pandemic Influenza Vaccine Sales Market Share by Manufacturer in 2021
    Figure 19. Global Pandemic Influenza Vaccine Revenue Market Share by Manufacturer in 2021
    Figure 20. Pandemic Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
    Figure 21. Top 3 Pandemic Influenza Vaccine Manufacturer (Revenue) Market Share in 2021
    Figure 22. Top 6 Pandemic Influenza Vaccine Manufacturer (Revenue) Market Share in 2021
    Figure 23. Global Pandemic Influenza Vaccine Sales Market Share by Region (2017-2028)
    Figure 24. Global Pandemic Influenza Vaccine Revenue Market Share by Region (2017-2028)
    Figure 25. North America Pandemic Influenza Vaccine Revenue (2017-2028) & (USD Million)
    Figure 26. Europe Pandemic Influenza Vaccine Revenue (2017-2028) & (USD Million)
    Figure 27. Asia-Pacific Pandemic Influenza Vaccine Revenue (2017-2028) & (USD Million)
    Figure 28. South America Pandemic Influenza Vaccine Revenue (2017-2028) & (USD Million)
    Figure 29. Middle East & Africa Pandemic Influenza Vaccine Revenue (2017-2028) & (USD Million)
    Figure 30. Global Pandemic Influenza Vaccine Sales Market Share by Type (2017-2028)
    Figure 31. Global Pandemic Influenza Vaccine Revenue Market Share by Type (2017-2028)
    Figure 32. Global Pandemic Influenza Vaccine Price by Type (2017-2028) & (USD/Dose)
    Figure 33. Global Pandemic Influenza Vaccine Sales Market Share by Application (2017-2028)
    Figure 34. Global Pandemic Influenza Vaccine Revenue Market Share by Application (2017-2028)
    Figure 35. Global Pandemic Influenza Vaccine Price by Application (2017-2028) & (USD/Dose)
    Figure 36. North America Pandemic Influenza Vaccine Sales Market Share by Type (2017-2028)
    Figure 37. North America Pandemic Influenza Vaccine Sales Market Share by Application (2017-2028)
    Figure 38. North America Pandemic Influenza Vaccine Sales Market Share by Country (2017-2028)
    Figure 39. North America Pandemic Influenza Vaccine Revenue Market Share by Country (2017-2028)
    Figure 40. United States Pandemic Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 41. Canada Pandemic Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 42. Mexico Pandemic Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 43. Europe Pandemic Influenza Vaccine Sales Market Share by Type (2017-2028)
    Figure 44. Europe Pandemic Influenza Vaccine Sales Market Share by Application (2017-2028)
    Figure 45. Europe Pandemic Influenza Vaccine Sales Market Share by Country (2017-2028)
    Figure 46. Europe Pandemic Influenza Vaccine Revenue Market Share by Country (2017-2028)
    Figure 47. Germany Pandemic Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 48. France Pandemic Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 49. United Kingdom Pandemic Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 50. Russia Pandemic Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 51. Italy Pandemic Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 52. Asia-Pacific Pandemic Influenza Vaccine Sales Market Share by Region (2017-2028)
    Figure 53. Asia-Pacific Pandemic Influenza Vaccine Sales Market Share by Application (2017-2028)
    Figure 54. Asia-Pacific Pandemic Influenza Vaccine Sales Market Share by Region (2017-2028)
    Figure 55. Asia-Pacific Pandemic Influenza Vaccine Revenue Market Share by Region (2017-2028)
    Figure 56. China Pandemic Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 57. Japan Pandemic Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 58. Korea Pandemic Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 59. India Pandemic Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 60. Southeast Asia Pandemic Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 61. Australia Pandemic Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 62. South America Pandemic Influenza Vaccine Sales Market Share by Type (2017-2028)
    Figure 63. South America Pandemic Influenza Vaccine Sales Market Share by Application (2017-2028)
    Figure 64. South America Pandemic Influenza Vaccine Sales Market Share by Country (2017-2028)
    Figure 65. South America Pandemic Influenza Vaccine Revenue Market Share by Country (2017-2028)
    Figure 66. Brazil Pandemic Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 67. Argentina Pandemic Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 68. Middle East & Africa Pandemic Influenza Vaccine Sales Market Share by Type (2017-2028)
    Figure 69. Middle East & Africa Pandemic Influenza Vaccine Sales Market Share by Application (2017-2028)
    Figure 70. Middle East & Africa Pandemic Influenza Vaccine Sales Market Share by Region (2017-2028)
    Figure 71. Middle East & Africa Pandemic Influenza Vaccine Revenue Market Share by Region (2017-2028)
    Figure 72. Turkey Pandemic Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 73. Egypt Pandemic Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 74. Saudi Arabia Pandemic Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 75. South Africa Pandemic Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 76. Manufacturing Cost Structure Analysis of Pandemic Influenza Vaccine in 2021
    Figure 77. Manufacturing Process Analysis of Pandemic Influenza Vaccine
    Figure 78. Pandemic Influenza Vaccine Industrial Chain
    Figure 79. Sales Channel: Direct Channel vs Indirect Channel
    Figure 80. Methodology
    Figure 81. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

CSL
GSK
Sanofi Pasteur
Mylan
AstraZeneca
Pfizer
Johnson & Johnson

Related Reports

Global Pandemic Influenza Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Global Pandemic Influenza Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

date 11 Mar 2021

date Pharma & Healthcare

The Pandemic Influenza Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Pandemic Influenza Vaccine Supply, Demand and Key Producers, 2023-2029

Global Pandemic Influenza Vaccine Supply, Demand and Key Producers, 2023-2029

date 20 Sep 2023

date Pharma & Healthcare

The global Pandemic Influenza Vaccine market size is expected to reach $ 11570 million by 2029, rising at a market growth of 5.3% CAGR during the forecast period (2023-2029).

Global Pandemic Influenza Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Pandemic Influenza Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 20 Sep 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Pandemic Influenza Vaccine market size was valued at USD 8056.5 million in 2022 and is forecast to a readjusted size of USD 11570 million by 2029 with a CAGR of 5.3% during review period.

Global Pandemic Influenza Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Pandemic Influenza Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Pandemic Influenza Vaccine market size was valued at USD 8056.5 million in 2023 and is forecast to a readjusted size of USD 11570 million by 2030 with a CAGR of 5.3% during review period.

Global Pandemic Influenza Vaccine Supply, Demand and Key Producers, 2024-2030

Global Pandemic Influenza Vaccine Supply, Demand and Key Producers, 2024-2030

date 02 Apr 2024

date Pharma & Healthcare

The global Pandemic Influenza Vaccine market size is expected to reach $ 11570 million by 2030, rising at a market growth of 5.3% CAGR during the forecast period (2024-2030).

Product Tags

pandemic influenza vaccine

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>